James P. Stevenson

Radiation Oncology
9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 17, 2026

Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 09, 2026

Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report.

Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report.

Journal: JTO clinical and research reports
Published: October 13, 2025

NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025.

NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 10, 2025

Sotorasib in Advanced KRAS G12C-Mutated NSCLC: Results From the Global Expanded Access Program, Including Patients With Poor Performance Status and a History of CNS Metastases.

Sotorasib in Advanced KRAS G12C-Mutated NSCLC: Results From the Global Expanded Access Program, Including Patients With Poor Performance Status and a History of CNS Metastases.

Journal: JTO clinical and research reports
Published: September 07, 2025

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).

Journal: Clinical lung cancer
Published: June 11, 2025

Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Thymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2025

Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study.

Long-term outcomes of Extensive-Stage small cell lung cancer treated with chemotherapy or Chemo-immunotherapy: A propensity score adjusted cohort study.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 30, 2025

Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 16, 2024

NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024.

NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 19, 2024

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: January 04, 2024

Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 06, 2023
Showing 1-12 of 62

Last Updated: 09/26/2026